BioSpace News Archive

The revolutionary trend in the era of cancer therapeutics is brought by the development of monoclonal antibodies. Further exploration in this field has led to the emergence of their enhanced “bispecifics” counterparts.

The latest market analysis report published by Reports and Data, titled ‘Global Paroxysmal Nocturnal Hemoglobinuria Market – Forecast to 2030,’ thoroughly examines the Paroxysmal Nocturnal Hemoglobinuria industry to provide essential data & information for the targeted readers.

Aspect Biosystems, a biotechnology company pioneering the development of bioprinted tissue therapeutics to transform how we treat disease, is pleased to announce the appointment of three new members to its Board of Directors: Dr. Nancy Krieger, Dr. Don Haut, and Dr. Devyn Smith.

The latest market analysis report published by Reports and Data, titled ‘Global Thalassemia Treatment Market – Forecast to 2030,’ thoroughly examines the Thalassemia Treatment industry to provide essential data & information for the targeted readers.

The global lung cancer screening market size was USD 2.80 Billion in 2021 and is expected to register a revenue CAGR of 8.1% during the forecast period, according to latest analysis by Emergen Research.

The global neurosurgery market size is expected to reach USD 4.91 Billion at a revenue CAGR of 4.6% in 2030, according to latest analysis by Emergen Research.

Neurona Therapeutics, a clinical-stage biotherapeutics company advancing regenerative cell therapies for the treatment of neurological disorders, today announced the presentation of a clinical case study from the initial dose cohort of the Phase 1/2 first-in-human epilepsy clinical trial of its lead program, NRTX-1001.

Medacta announced the completion of the first revision surgeries in the US using MyKnee® R, the game-changing technology for streamlining and guiding total knee revision surgeries where even highly experienced surgeons can face complex and time-consuming procedures.

OneOncology, the platform for the nation’s leading independent oncology practices, announced two nationally renowned keynote speakers for the first OneOncology Annual Conference for providers scheduled for November 11-13 in Nashville.

The latest market analysis report published by Reports and Data, titled ‘Global Hematopoietic Stem Cell Transplantation (HSCT) Market – Forecast to 2030,’ thoroughly examines the Hematopoietic Stem Cell Transplantation (HSCT) industry to provide essential data & information for the targeted readers.